Projects per year
Personal profile
Research interests
Miller Lab Consortium. To date, our team has treated more than 400 patients with natural killer cell infusions and over a hundred patients with therapies that activate their own natural killer cells. We've retrospectively analyzed more than 5000 patients and enrolled more than 500 patients in prospective trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
Miller, J. S. (PI), Antonarakis, E. (CoI), Chen, C. C. (CoI), Cichocki, F. M. (CoI), Davis, Z. B. (CoI), Dehm, S. M. (CoI), Felices, M. (CoI), Luo, X. (CoI) & Provenzano, P. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
8/1/23 → 7/31/30
Project: Research project
-
Liver Tissue Distribution System (LTDS)
Davis, Z. B. (PI)
NATIONAL INSTITUTES OF HEALTH (NIH)
11/29/23 → 11/28/24
Project: Research project
-
Liver Tissue Distribution System (LTDS)
Davis, Z. B. (PI) & Grzywacz, B. J. (Prior Principal Investigator)
NIH NAT'L INST OF CHILD HEALTH/HUMAN DEV
9/29/22 → 5/28/24
Project: Research project
-
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
Dixon, K., Snyder, K. M., Khaw, M., Hullsiek, R. H., Davis, Z. B., Matson, A. W., Shirinbak, S., Hancock, B., Bjordahl, R., Hosking, M., Miller, J. S., Valamehr, B., Wu, J. & Walcheck, B., 2024, In: Frontiers in immunology. 15, 1407567.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection
Miller, J. S., Rhein, J., Davis, Z. B., Cooley, S. A., McKenna, D., Anderson, J. L., Escandón, K., Wieking, G., Reichel, J., Thorkelson, A., Jorstad, S. L., Safrit, J. T., Soon-Shiong, P., Beilman, G. J., Chipman, J. G. & Schacker, T. W., May 15 2024, In: Journal of Infectious Diseases. 229, 5, p. 1256-1265 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Advances in NK cell therapy for brain tumors
Fares, J., Davis, Z. B., Rechberger, J. S., Toll, S. A., Schwartz, J. D., Daniels, D. J., Miller, J. S. & Khatua, S., Dec 2023, In: npj Precision Oncology. 7, 1, 17.Research output: Contribution to journal › Review article › peer-review
Open Access21 Scopus citations -
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Snyder, K. M., Dixon, K. J., Davis, Z., Hosking, M., Hart, G., Khaw, M., Matson, A., Bjordahl, R., Hancock, B., Shirinbak, S., Miller, J. S., Valamehr, B., Wu, J. & Walcheck, B., Dec 6 2023, In: Journal for ImmunoTherapy of Cancer. 11, 12, e007280.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia
Cichocki, F., Goodridge, J. P., Bjordahl, R., Mahmood, S., Davis, Z. B., Gaidarova, S., Abujarour, R., Groff, B., Witty, A., Wang, H., Tuininga, K., Kodal, B., Felices, M., Bonello, G., Huffman, J., Dailey, T., Lee, T. T., Walcheck, B., Valamehr, B. & Miller, J. S., Dec 8 2022, In: Blood. 140, 23, p. 2451-2462 12 p.Research output: Contribution to journal › Article › peer-review
54 Scopus citations